Paclitaxel nanoparticles for the potential treatment of brain tumors
- 13 August 2004
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 99 (2), 259-269
- https://doi.org/10.1016/j.jconrel.2004.07.006
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Stereotactic radiosurgery for multiple brain metastases from breast carcinomaCancer, 2004
- Gadolinium-Loaded Nanoparticles Engineered from Microemulsion TemplatesDrug Development and Industrial Pharmacy, 2002
- Hyperthermia-induced Nuclear Translocation of Transcription Factor YB-1 Leads to Enhanced Expression of Multidrug Resistance-related ABC TransportersJournal of Biological Chemistry, 2001
- Identification of prognostic factors in patients with brain metastases: a review of 1292 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Pharmaceutical aspects of paclitaxelInternational Journal of Pharmaceutics, 1998
- Role of P‐Glycoprotein in the Blood‐Brain Transport of Colchicine and VinblastineJournal of Neurochemistry, 1996
- Tissue distribution, metabolism and excretion of paclitaxel in miceAnti-Cancer Drugs, 1996
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.JCI Insight, 1995
- A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumorsJournal of Neuro-Oncology, 1994
- Chemotherapy for malignant gliomasJournal of Neurosurgery, 1988